Acta Med. 2015, 58: 3-8

https://doi.org/10.14712/18059694.2015.84

Extracorporeal Elimination of Circulating Pegylated Liposomal Doxorubicin (PLD) to Enhance the Benefit of Cytostatic Therapy in Platinum-Resistant Ovarian Cancer Patients

Ondřej Kubečeka, Milan Bláhab, Daniel Diaz-Garciac, Stanislav Filipa

aDepartment of Oncology and Radiotherapy, Charles University in Prague, Medical Faculty and University Hospital in Hradec Králové, Czech Republic
b4th Department of Internal Medicine – Haematology, Charles University in Prague, Medical Faculty and University Hospital in Hradec Králové, Czech Republic
cDepartment of Histology and Embryology, Charles University in Prague, Medical Faculty and University Hospital in Hradec Králové, Czech Republic

Received November 20, 2014
Accepted April 1, 2015

Crossref Cited-by Linking

  • Filip Stanislav, Kubeček Ondřej, Špaček Jiří, Martínková Jiřina, Bláha Milan: Extracorporeal apheresis system - A nanoparticle drugs' elimination method to enhance the benefit of cytostatic therapy in cancer patients. J Appl Biomed 2016, 14, 91. <https://doi.org/10.1016/j.jab.2015.11.002>
Crossref Cited-by Linking logo